Csenge Advisory Group’s Fabrinet FN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$245K Sell
470
-253
-35% -$129K 0.01% 637
2025
Q4
$329K Sell
723
-10
-1% -$4.35K 0.01% 542
2025
Q3
$267K Buy
+733
New +$241K 0.01% 576
2022
Q2
Sell
-2,129
Closed -$224K 608
2022
Q1
$224K Sell
2,129
-329
-13% -$34.8K 0.02% 576
2021
Q4
$236K Sell
2,458
-41
-2% -$4.54K 0.02% 495
2021
Q3
$261K Buy
2,499
+41
+2% +$4.02K 0.02% 499
2021
Q2
$236K Buy
+2,458
New +$220K 0.02% 498
2018
Q4
Sell
-2,361
Closed -$117K 645
2018
Q3
$117K Buy
+2,361
New +$101K 0.05% 213

Other funds holding FN

Csenge Advisory Group's FN Position: Q1 2026 in Review

Csenge Advisory Group reduced its Fabrinet (FN) stake by 35% in Q1 2026, selling an estimated $129K and leaving 470 shares worth $245K. The position accounts for 0.01% of the portfolio, ranked #637.

Csenge Advisory Group first reported a position in FN in Q3 2018 and has held it in 8 quarters since. The position peaked at $329K in Q4 2025. 662 funds tracked by Wall St. Rank hold FN as of Q1 2026.

  • Csenge Advisory Group held 470 shares of Fabrinet worth $245K as of Q1 2026.
  • Csenge Advisory Group sold 253 Fabrinet shares in Q1 2026, an estimated $129K.
  • Fabrinet made up 0.01% of Csenge Advisory Group's portfolio in Q1 2026, its #637 holding.
  • Csenge Advisory Group first reported a position in Fabrinet in Q3 2018 and has held it in 8 quarters since.
  • Csenge Advisory Group's Fabrinet position peaked at $329K in Q4 2025.
  • 662 funds tracked by Wall St. Rank held Fabrinet as of Q1 2026.

Based on Csenge Advisory Group's 13F filing for Q1 2026, filed 30 Apr 2026.